Management of cardiovascular disease using an mHealth tool: a randomized clinical trial
Abstract Atherosclerotic cardiovascular disease (ASCVD) is a leading cause of death and morbidity worldwide. This randomized controlled, single-center, open-label trial tested the impact of a mobile health (mHealth) service tool optimized for ASCVD patient care. Patients with clinical ASCVD were enr...
Guardado en:
Autores principales: | Si-Hyuck Kang, Hyunyoung Baek, Jihoon Cho, Seok Kim, Hee Hwang, Wonjae Lee, Jin Joo Park, Yeonyee E. Yoon, Chang-Hwan Yoon, Young-Seok Cho, Tae-Jin Youn, Goo-Yeong Cho, In-Ho Chae, Dong-Ju Choi, Sooyoung Yoo, Jung-Won Suh |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/173b60bfeae74628b592820139354d21 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Combined effects of ARNI and SGLT2 inhibitors in diabetic patients with heart failure with reduced ejection fraction
por: Hyue Mee Kim, et al.
Publicado: (2021) -
Prescribable mHealth apps identified from an overview of systematic reviews
por: Oyungerel Byambasuren, et al.
Publicado: (2018) -
Scoping review: the empowerment of Alzheimer’s Disease caregivers with mHealth applications
por: Eunhee Kim, et al.
Publicado: (2021) -
mHealth and wearable technology should replace motor diaries to track motor fluctuations in Parkinson’s disease
por: M. Kelley Erb, et al.
Publicado: (2020) -
Comparison of proton pump inhibitors and histamine 2 receptor antagonists for stress ulcer prophylaxis in the intensive care unit
por: Myung Jin Song, et al.
Publicado: (2021)